| Male (n = 156) | Female (n = 407) | P |
---|---|---|---|
Age (years) | 49.6 ± 8.5 | 51.4 ± 8.9 | <.05 |
Chronic bronchitis | 88 (56.4%) | 271 (66.6%) | 0.395 |
Asthma | 66 (42.3%) | 135 (33.2%) | |
Emphysema | 2 (1.3%) | 1 (0.2%) | |
FEV1 (l) | 2.51 ± 0.75 | 1.93 ± 0.50 | <.001 |
FEV1 % predicted | 77 ± 21 | 89 ± 21 | <.001 |
FVC (l) | 3.50 ± 0.77 | 2.59 ± 0.52 | <.001 |
FVC % predicted | 91 ± 17 | 100 ± 16 | <.01 |
VC (l) | 3.67 ± 0.74 | 2.71 ± 0.51 | <.001 |
VC % predicted | 102 ± 18 | 108 ± 17 | <.01 |
FEV1/FVC (%) | 71.4 ± 14.8 | 74.5 ± 10.9 | <.05 |
Dyspnea | 32 (20.5%) | 79 (19.4%) | 0.361 |
 | 91 (58.3%) | 266 (65.4%) | |
 | 28 (17.9%) | 53 (13.0%) | |
 | 3 (1.9%) | 5 (1.2%) | |
 | 1 (0.6%) | 0 (0%) | |
Wheeze | 47 (30.1%) | 161 (39.6%) | <.05 |
 | 59 (37.8%) | 156 (38.3%) | |
 | 40 (25.6%) | 75 (18.4%) | |
 | 8 (5.1%) | 13 (3.2%) | |
 | 1 (0.6%) | 1 (0.2%) | |
Cough and sputum | 13 (8.3%) | 24 (5.9%) | 0.623 |
 | 87 (55.8%) | 228 (56.0%) | |
 | 49 (31.4%) | 144 (35.4%) | |
 | 6 (3.8%) | 8 (2.0%) | |
 | 1 (0.6%) | 1 (0.2%) |  |